These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 35315179)

  • 1. Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome.
    Hasler WL; Grabauskas G; Singh P; Owyang C
    Neurogastroenterol Motil; 2022 Jul; 34(7):e14339. PubMed ID: 35315179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E
    Grabauskas G; Wu X; Gao J; Li JY; Turgeon DK; Owyang C
    Gastroenterology; 2020 Jun; 158(8):2195-2207.e6. PubMed ID: 32084424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome.
    Liu DR; Xu XJ; Yao SK
    World J Gastroenterol; 2018 Jan; 24(1):46-57. PubMed ID: 29358881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
    Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
    Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
    Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
    Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G
    Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside.
    Zhang L; Song J; Hou X
    J Neurogastroenterol Motil; 2016 Apr; 22(2):181-92. PubMed ID: 26755686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?
    Braak B; Klooker TK; Wouters MM; Welting O; van der Loos CM; Stanisor OI; van Diest S; van den Wijngaard RM; Boeckxstaens GE
    Am J Gastroenterol; 2012 May; 107(5):715-26. PubMed ID: 22488080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
    Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M
    Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome.
    Barbara G; Wang B; Stanghellini V; de Giorgio R; Cremon C; Di Nardo G; Trevisani M; Campi B; Geppetti P; Tonini M; Bunnett NW; Grundy D; Corinaldesi R
    Gastroenterology; 2007 Jan; 132(1):26-37. PubMed ID: 17241857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal Serotonin Reuptake Transporter Expression in Irritable Bowel Syndrome Is Modulated by Gut Microbiota Via Mast Cell-Prostaglandin E2.
    Gao J; Xiong T; Grabauskas G; Owyang C
    Gastroenterology; 2022 Jun; 162(7):1962-1974.e6. PubMed ID: 35167867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome.
    Zhang Y; Qin G; Liu DR; Wang Y; Yao SK
    World J Gastroenterol; 2019 Jan; 25(2):269-281. PubMed ID: 30670915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between dectin-1 and mast cells in patients with diarrhea-predominant irritable bowel syndrome.
    Chi Y; Li C; Wu LH; Wang HH
    Scand J Gastroenterol; 2020 Jul; 55(7):762-768. PubMed ID: 32493087
    [No Abstract]   [Full Text] [Related]  

  • 15. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation?
    Piche T
    Neurogastroenterol Motil; 2014 Mar; 26(3):296-302. PubMed ID: 24548256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients.
    Doyle LA; Sepehr GJ; Hamilton MJ; Akin C; Castells MC; Hornick JL
    Am J Surg Pathol; 2014 Jun; 38(6):832-43. PubMed ID: 24618605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.
    Barbara G; Stanghellini V; De Giorgio R; Cremon C; Cottrell GS; Santini D; Pasquinelli G; Morselli-Labate AM; Grady EF; Bunnett NW; Collins SM; Corinaldesi R
    Gastroenterology; 2004 Mar; 126(3):693-702. PubMed ID: 14988823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of nerve growth factor correlates with visceral hypersensitivity and impaired gut barrier function in diarrhoea-predominant irritable bowel syndrome: a preliminary explorative study.
    Xu XJ; Zhang YL; Liu L; Pan L; Yao SK
    Aliment Pharmacol Ther; 2017 Jan; 45(1):100-114. PubMed ID: 27862119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal barrier defects in irritable bowel syndrome. Who left the door open?
    Barbara G
    Am J Gastroenterol; 2006 Jun; 101(6):1295-8. PubMed ID: 16771952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome.
    Zhou Q; Zhang B; Verne GN
    Pain; 2009 Nov; 146(1-2):41-6. PubMed ID: 19595511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.